BioMark Diagnostics Inc
CNSX:BUX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
BioMark Diagnostics Inc
CNSX:BUX
|
CA |
|
Mds Retailing Tbk
IDX:LPPF
|
ID |
|
Moncler SpA
MIL:MONC
|
IT |
|
JPMorgan Chase & Co
XETRA:CMC
|
US |
|
Canon Inc
OTC:CAJFF
|
JP |
|
Lu-Ve SpA
MIL:LUVE
|
IT |
|
National Oxygen Ltd
BSE:507813
|
IN |
|
C
|
Cipherlab Co Ltd
TPEX:6160
|
TW |
|
P
|
Prysmian SpA
XMUN:AEU
|
IT |
|
Rincon Resources Ltd
ASX:RCR
|
AU |
|
Rakuten Group Inc
TSE:4755
|
JP |
|
H & M Hennes & Mauritz AB
STO:HM B
|
SE |
|
H
|
Hapag Lloyd AG
SWB:HLAG
|
DE |
|
Shoei Co Ltd
OTC:SHOFF
|
JP |
|
Shoprite Holdings Ltd
F:HY7
|
ZA |
|
BASF SE
OTC:BFFAF
|
DE |
|
S
|
Sigdo Koppers SA
SGO:SK
|
CL |
|
Tokyo Century Corp
F:59O
|
JP |
|
R
|
Randstad NV
F:RSH
|
NL |
|
L
|
Lepermislibre SA
PAR:ALLPL
|
FR |
|
A
|
Appulse Corp
XTSX:APL
|
CA |
|
Moncler SpA
OTC:MONRF
|
IT |
|
Bank Rakyat Indonesia (Persero) Tbk PT
F:BYRA
|
ID |
Bankruptcy Probability
BioMark Diagnostics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
BioMark Diagnostics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CA |
B
|
BioMark Diagnostics Inc
CNSX:BUX
|
50m CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
242B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
421.6B CNY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
48.9B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
40.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
BeOne Medicines AG
SSE:688235
|
236.2B CNY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Genmab A/S
CSE:GMAB
|
163.1B DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DE |
|
Biontech SE
NASDAQ:BNTX
|
22.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Medpace Holdings Inc
NASDAQ:MEDP
|
18.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| LU |
|
Eurofins Scientific SE
PAR:ERF
|
14.6B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Ascendis Pharma A/S
NASDAQ:ASND
|
16.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
BioMark Diagnostics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, BioMark Diagnostics Inc has total debt of 927.8k CAD. This includes both short-term (0 CAD) and long-term (927.8k CAD) debt.
You can find a full breakdown on its Balance Sheet.